----- 生长激素抑制素同型物
This supplement issue focuses on important aspects of somatostatin, its long-acting analogues and its receptor subtypes. Internationally renowned basic and clinical scientists discuss the rapidly advancing knowledge about how somatostatin and its analogues act on its targets, and the implications of these advances for the diagnosis and treatment of various diseases. The contributions are organized into sections dealing with the place of somatostatin and its analogues in the regulation of tumor growth, in the diagnosis and treatment of neuroendocrine gastro-enteropancreatic tumors and in the treatment of non-endocrine digestive diseases. Each article reflects the state of the art in our knowledge and provides a timely summary and invaluable reference source for all those interested in this fascinating hormone.
{{comment.content}}